Symptom-centric view
Pain
Substances reporting Pain disproportionately — ranked by ROR.
showing 10 of 10
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 2.3 [2.1–2.5] | 569 | injectables | new |
nicotinamide Niacinamide | 11.3 [10.3–12.4] | 615 | longevity | new |
| 2.6 [2.6–2.7] | 50,489 | algemeen | new | |
| 3.1 [3.0–3.1] | 13,079 | algemeen | new | |
| 2.7 [2.6–2.7] | 18,105 | algemeen | new | |
| 5.8 [5.5–6.1] | 2,067 | algemeen | new | |
| 2.7 [2.6–2.7] | 18,134 | algemeen | new | |
| 2.7 [2.7–2.8] | 48,851 | algemeen | new | |
| 6.4 [6.3–6.5] | 21,580 | algemeen | new | |
| 3.5 [3.3–3.7] | 1,501 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).